Preventability of Hospital-Acquired Venous Thromboembolism

JAMA Surg. 2015 Sep;150(9):912-5. doi: 10.1001/jamasurg.2015.1340.
No abstract available

MeSH terms

  • Baltimore / epidemiology
  • Catheterization / adverse effects*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Incidence
  • Inpatients*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Venous Thromboembolism / epidemiology
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*

Substances

  • Fibrinolytic Agents